Dr. Mani Foroohar, Leerink Partners, joins ‘Closing Bell Overtime’ to talk Moderna prices climbing on positive drug trial.
Baseline characteristics in Moderna cancer vaccine ‘misleading’: Leerink’s Dr. Mani Foroohar
Related posts
-
Bloomberg Previews Jackson Hole Symposium
Bloomberg TelevisionSat, August 22, 2026 10:42pmURL:Embed:Bloomberg’s Joe Weisenthal, Lisa Abramowicz, Tracy Alloway and Tom Keene preview... -
US Colleges Face a Shrinking Student Pipeline
Bloomberg TelevisionSat, August 22, 2026 10:42pmURL:Embed:US colleges are confronting a prolonged demographic squeeze as the number... -
How a bin store became the heart of a small town
Yahoo FinanceSat, August 22, 2026 10:42pmURL:Embed:Sharon Baugh turned other retailers’ unwanted returns into affordable $5 finds...